Today, we look at the 'World Alzheimer Report 2026' published by Alzheimer’s Disease International (ADI) in September 2026.

For more than three decades, the dominant hypothesis in Alzheimer’s disease research has rested on a single idea: that the ...

An expert doctor explains the difference between Alzheimer's versus dementia, how you can impact your long-term brain health ...

Treatment options are expanding, and experts are turning their attention to prevention ...

UK dementia research receives £45M+ in public funding to accelerate early-stage drug discovery, bridging the "valley of death" gap between lab concepts and clinical trials. - Private firms dominate ...

For decades, research has focused on treating Alzheimer’s disease after symptoms appear. PrevenTRON addresses a different ...

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

A mouse study from WashU Medicine suggests a new approach to preventing brain cell death from certain neurological diseases.

- PINK ETF, near its 52-week high, holds 53 diverse healthcare 861075+0.33% businesses including biotech 861042+0.30%, ...

There is no treatment available today to stop the death of brain cells in neurodegenerative diseases known as tauopathies, including Alzheimer's disease, in which twisted clumps of a protein called ...

Patients with atypical Alzheimer disease frequently fail to meet the clinical criteria required to receive targeted anti-amyloid therapies.

Much of what we know about what causes Alzheimer’s disease – a type of dementia – can be credited to individuals with Down ...